Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9745 - 9752 of 11616 results
6 Little Known Facts About H-1B Visas
September 11, 2014| Blog| Viewpoint
Government Issues New Rules for Religious Employers, But Health Plans, TPAs, And PBMs Are Still On The Hook To Provide Contraceptive Coverage
September 10, 2014| Blog| Viewpoint
Federation of State Medical Boards Releases Interstate Licensure Compact
September 10, 2014| Blog| Viewpoint
FDA Issues Draft Guidance Regarding Controlled Correspondence from Generics Manufacturers
September 9, 2014| Blog| Viewpoint
ML Strategies Energy and Environment Update: Week of 9/8/2014
September 9, 2014| Blog| Viewpoint
Delaware Court of Chancery Upholds North Carolina Forum Selection Bylaw for Delaware Corporation
September 9, 2014| Blog| Viewpoint
The Affordable Care Act—Countdown to Compliance for Employers, Week 16: So What, Exactly, is an “Offer of Coverage”?
September 8, 2014| Blog| Viewpoint
Law360: How Employers Can Avoid Getting Blitzed By Fantasy Football
September 8, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.